<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-7VCVYNX9</identifier><date>2012</date><creator>Mlinarič-Raščan, Irena</creator><creator>Schmidt, Jan</creator><creator>Šmid, Alenka</creator><relation>documents/doc/7/URN_NBN_SI_doc-7VCVYNX9_001.htm</relation><relation>documents/doc/7/URN_NBN_SI_doc-7VCVYNX9_001.pdf</relation><relation>documents/doc/7/URN_NBN_SI_doc-7VCVYNX9_001.txt</relation><format format_type="issue">3</format><format format_type="volume">63</format><format format_type="type">article</format><format format_type="extent">str. 162-167</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3290737</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-7VCVYNX9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">drug</subject><subject language_type_id="slv">farmakovigilanca</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">toksičnost</subject><subject language_type_id="slv">zakonodaja</subject><subject language_type_id="slv">zdravila</subject><title>Monitoring of adverse drug reactions</title><title>Spremljanje neželenih učinkov zdravil</title></Record>